(MS) Morgan Stanley - Overview
Stock: Banking, Investments, Brokerage, Advisory
| Risk 5d forecast | |
|---|---|
| Volatility | 43.6% |
| Relative Tail Risk | -7.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 6.42 |
| Character TTM | |
|---|---|
| Beta | 1.490 |
| Beta Downside | 1.446 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.24% |
| CAGR/Max DD | 0.83 |
EPS (Earnings per Share)
Revenue
Description: MS Morgan Stanley March 04, 2026
Morgan Stanley (NYSE: MS) is a global financial holding company. It provides a range of financial products and services to institutional and individual clients across the Americas, Asia, Europe, the Middle East, and Africa. The company operates through three core segments: Institutional Securities, Wealth Management, and Investment Management. This diversified model is common among large financial institutions.
The Institutional Securities segment offers capital raising, financial advisory, and sales and trading services for equity and fixed income products. This includes underwriting debt and equity, advising on mergers and acquisitions, and providing prime brokerage services. Investment banking and brokerage is a competitive sector, often influenced by global economic conditions and regulatory changes.
Wealth Management provides brokerage, investment advisory, custody, cash management, and lending services to individuals. This segment focuses on long-term client relationships and recurring revenue streams. The Investment Management segment offers asset management services across various asset classes to a diverse client base, including pension funds, endowments, and high-net-worth individuals. Asset management typically involves managing portfolios for a fee.
To gain deeper insights into Morgan Stanleys financial performance and valuation, consider exploring its detailed financials on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 16.86b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -1.09 > 1.0 |
| NWC/Revenue: 81.92% < 20% (prev -244.1%; Δ 326.0% < -1%) |
| CFO/TA -0.01 > 3% & CFO -17.89b > Net Income 16.86b |
| Net Debt (363.87b) to EBITDA (26.56b): 13.70 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.59b) vs 12m ago -0.93% < -2% |
| Gross Margin: 57.48% > 18% (prev 0.56%; Δ 5693 % > 0.5%) |
| Asset Turnover: 8.81% > 50% (prev 8.49%; Δ 0.32% > 0%) |
| Interest Coverage Ratio: 0.45 > 6 (EBITDA TTM 26.56b / Interest Expense TTM 49.02b) |
Altman Z'' 0.90
| A: 0.07 (Total Current Assets 654.69b - Total Current Liabilities 559.57b) / Total Assets 1420.27b |
| B: 0.08 (Retained Earnings 115.09b / Total Assets 1420.27b) |
| C: 0.02 (EBIT TTM 21.95b / Avg Total Assets 1317.67b) |
| D: 0.08 (Book Value of Equity 108.83b / Total Liabilities 1307.62b) |
| Altman-Z'' Score: 0.90 = BB |
Beneish M -2.85
| DSRI: 1.18 (Receivables 114.72b/86.16b, Revenue 116.11b/103.14b) |
| GMI: 0.97 (GM 57.48% / 55.61%) |
| AQI: 0.90 (AQ_t 0.54 / AQ_t-1 0.60) |
| SGI: 1.13 (Revenue 116.11b / 103.14b) |
| TATA: 0.02 (NI 16.86b - CFO -17.89b) / TA 1420.27b) |
| Beneish M-Score: -2.85 (Cap -4..+1) = A |
What is the price of MS shares?
Over the past week, the price has changed by -1.68%, over one month by -9.27%, over three months by -3.95% and over the past year by +31.96%.
Is MS a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 17
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 195.5 | 17.8% |
| Analysts Target Price | 195.5 | 17.8% |
MS Fundamental Data Overview February 28, 2026
P/E Forward = 15.2672
P/S = 3.7612
P/B = 2.8037
P/EG = 1.9566
Revenue TTM = 116.11b USD
EBIT TTM = 21.95b USD
EBITDA TTM = 26.56b USD
Long Term Debt = 349.39b USD (from longTermDebt, last quarter)
Short Term Debt = 144.05b USD (from shortTermDebt, last quarter)
Debt = 475.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 363.87b USD (from netDebt column, last quarter)
Enterprise Value = 632.72b USD (264.39b + Debt 475.56b - CCE 107.23b)
Interest Coverage Ratio = 0.45 (Ebit TTM 21.95b / Interest Expense TTM 49.02b)
EV/FCF = -35.37x (Enterprise Value 632.72b / FCF TTM -17.89b)
FCF Yield = -2.83% (FCF TTM -17.89b / Enterprise Value 632.72b)
FCF Margin = -15.41% (FCF TTM -17.89b / Revenue TTM 116.11b)
Net Margin = 14.52% (Net Income TTM 16.86b / Revenue TTM 116.11b)
Gross Margin = 57.48% ((Revenue TTM 116.11b - Cost of Revenue TTM 49.37b) / Revenue TTM)
Gross Margin QoQ = 59.60% (prev 56.85%)
Tobins Q-Ratio = 0.45 (Enterprise Value 632.72b / Total Assets 1420.27b)
Interest Expense / Debt = 2.54% (Interest Expense 12.10b / Debt 475.56b)
Taxrate = 23.19% (1.34b / 5.76b)
NOPAT = 16.86b (EBIT 21.95b * (1 - 23.19%))
Current Ratio = 1.17 (Total Current Assets 654.69b / Total Current Liabilities 559.57b)
Debt / Equity = 4.26 (Debt 475.56b / totalStockholderEquity, last quarter 111.63b)
Debt / EBITDA = 13.70 (Net Debt 363.87b / EBITDA 26.56b)
Debt / FCF = -20.34 (negative FCF - burning cash) (Net Debt 363.87b / FCF TTM -17.89b)
Total Stockholder Equity = 109.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.28% (Net Income 16.86b / Total Assets 1420.27b)
RoE = 15.45% (Net Income TTM 16.86b / Total Stockholder Equity 109.15b)
RoCE = 4.79% (EBIT 21.95b / Capital Employed (Equity 109.15b + L.T.Debt 349.39b))
RoIC = 3.81% (NOPAT 16.86b / Invested Capital 442.94b)
WACC = 5.33% (E(264.39b)/V(739.95b) * Re(11.40%) + D(475.56b)/V(739.95b) * Rd(2.54%) * (1-Tc(0.23)))
Discount Rate = 11.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.05%
[DCF] Fair Price = unknown (Cash Flow -17.89b)
EPS Correlation: 67.67 | EPS CAGR: 7.83% | SUE: 1.19 | # QB: 8
Revenue Correlation: 93.93 | Revenue CAGR: 21.71% | SUE: 3.64 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.74 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+12 | Analysts=17
EPS current Year (2026-12-31): EPS=11.33 | Chg7d=+0.000 | Chg30d=+0.042 | Revisions Net=+23 | Growth EPS=+11.0% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=12.25 | Chg7d=+0.000 | Chg30d=+0.034 | Revisions Net=+15 | Growth EPS=+8.1% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: +1.00 (12 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 11.4% - Earnings Yield 6.1%)
[Growth] Growth Spread = +7.0% (Analyst 12.3% - Implied 5.3%)